The DOI matches its Crossref record; 65 of the 65 references it cites were found in a registry or an index.
Coal tar induces AHR-dependent skin barrier repair in atopic dermatitis
Open accessAbstract
Topical application of coal tar is one of the oldest therapies for atopic dermatitis (AD), a T helper 2 (Th2) lymphocyte-mediated skin disease associated with loss-of-function mutations in the skin barrier gene, filaggrin (FLG). Despite its longstanding clinical use and efficacy, the molecular mechanism of coal tar therapy is unknown. Using organotypic skin models with primary keratinocytes from AD patients and controls, we found that coal tar activated the aryl hydrocarbon receptor (AHR), resulting in induction of epidermal differentiation. AHR knockdown by siRNA completely abrogated this effect. Coal tar restored filaggrin expression in FLG-haploinsufficient keratinocytes to wild-type levels, and counteracted Th2 cytokine-mediated downregulation of skin barrier proteins. In AD patients, coal tar completely restored expression of major skin barrier proteins, including filaggrin. Using organotypic skin models stimulated with Th2 cytokines IL-4 and IL-13, we found coal tar to diminish spongiosis, apoptosis, and CCL26 expression, all AD hallmarks. Coal tar interfered with Th2 cytokine signaling via dephosphorylation of STAT6, most likely due to AHR-regulated activation of the NRF2 antioxidative stress pathway. The therapeutic effect of AHR activation herein described opens a new avenue to reconsider AHR as a pharmacological target and could lead to the development of mechanism-based drugs for AD.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Interestingly, coal tar has been shown to bind to AhR and to restore the expression of filaggrin, as shown by immunohistochemistry and transcriptomic analysis59.”
From Atopic dermatitis: an expanding therapeutic pipeline for a complex disease (2022) · cites this paper as [59]
In the citing paper
“Activation of NRF2 by AHR ligands such as coal tar abolished IL-4/IL-13–mediated inhibition of epidermal barrier proteins such as FLG and LOR (42, 56).”
From Particulate matter causes skin barrier dysfunction. (2021) · cites this paper as [56]
Citations
Cites
Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT Method
Livak, K. J., & Schmittgen, T. D. (2001) · Methods · doi:10.1006/meth.2001.1262 · Cited by 180,860
Palmer, C. N. A., Irvine, A. D., Terron-Kwiatkowski, A., Zhao, Y., Liao, H., Lee, S. P., Goudie, D. R., Sandilands, A., Campbell, L. E., Smith, F. J. D., et al. (2006) · Nature Genetics · doi:10.1038/ng1767 · Cited by 2,978
Control of Treg and TH17 cell differentiation by the aryl hydrocarbon receptor
Quintana, F. J., Basso, A. S., Iglesias, A. H., Korn, T., Farez, M. F., Bettelli, E., Caccamo, M., Oukka, M., & Weiner, H. L. (2008) · Nature · doi:10.1038/nature06880 · Cited by 1,865
The aryl hydrocarbon receptor links TH17-cell-mediated autoimmunity to environmental toxins
Veldhoen, M., Hirota, K., Westendorf, A. M., Buer, J., Dumoutier, L., Renauld, J.-C., & Stockinger, B. (2008) · Nature · doi:10.1038/nature06881 · Cited by 1,634
Stat6 Is Required for Mediating Responses to IL-4 and for the Development of Th2 Cells
Kaplan, M. H., Schindler, U., Smiley, S. T., & Grusby, M. J. (1996) · Immunity · doi:10.1016/s1074-7613(00)80439-2 · Cited by 1,629
Lack of IL-4-induced Th2 response and IgE class switching in mice with disrupted Stat6 gene
Shimoda, K., van Deursent, J., Sangster, M. Y., Sarawar, S. R., Carson, R. T., Tripp, R. A., Chu, C., Quelle, F. W., Nosaka, T., Vignali, D. A. A., et al. (1996) · Nature · doi:10.1038/380630a0 · Cited by 1,278
Filaggrin Mutations Associated with Skin and Allergic Diseases
Irvine, A. D., McLean, W. H. I., & Leung, D. Y. M. (2011) · New England Journal of Medicine · doi:10.1056/nejmra1011040 · Cited by 1,217
Atopic dermatitis: a disease of altered skin barrier and immune dysregulation
Boguniewicz, M., & Leung, D. Y. M. (2011) · Immunological Reviews · doi:10.1111/j.1600-065x.2011.01027.x · Cited by 1,100
Loss-of-function mutations in the gene encoding filaggrin cause ichthyosis vulgaris
Smith, F. J. D., Irvine, A. D., Terron-Kwiatkowski, A., Sandilands, A., Campbell, L., Zhao, Y., Liao, H., Evans, A. T., Goudie, D. R., Lewis‐Jones, S., et al. (2006) · Nature Genetics · doi:10.1038/ng1743 · Cited by 1,026
The Aryl Hydrocarbon Receptor Regulates Gut Immunity through Modulation of Innate Lymphoid Cells
Qiu, J., Heller, J. J., Guo, X., Chen, Z. E., Fish, K., Fu, Y., & Zhou, L. (2011) · Immunity · doi:10.1016/j.immuni.2011.11.011 · Cited by 887
Cited by
Sorted by citations
Guidelines of care for the management of atopic dermatitis
Eichenfield, L. F., Tom, W. L., Chamlin, S. L., Feldman, S. R., Hanifin, J. M., Simpson, E. L., Berger, T. G., Bergman, J. N., Cohen, D. E., Cooper, K. D., et al. (2013) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2013.10.010 · Cited by 1,305
Guidelines of care for the management of atopic dermatitis
Eichenfield, L. F., Tom, W. L., Berger, T. G., Krol, A. L., Paller, A. S., Schwarzenberger, K., Bergman, J. N., Chamlin, S. L., Cohen, D. E., Cooper, K. D., et al. (2014) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2014.03.023 · Cited by 1,220
The aryl hydrocarbon receptor: multitasking in the immune system
Stockinger, B., Meglio, P. D., Gialitakis, M., & Duarte, J. H. (2014) · Annual Review of Immunology · doi:10.1146/annurev-immunol-032713-120245 · Cited by 909
Aryl hydrocarbon receptor ligands in cancer: friend and foe
Murray, I. A., Patterson, A. D., & Perdew, G. H. (2014) · Nature reviews. Cancer · doi:10.1038/nrc3846 · Cited by 916
Atopic dermatitis: an expanding therapeutic pipeline for a complex disease
Bieber, T. (2022) · Nature Reviews Drug Discovery · doi:10.1038/s41573-021-00266-6 · Cited by 623
Vogel, C. F. A., Winkle, L. S. V., Esser, C., & Haarmann‐Stemmann, T. (2020) · Redox Biology · doi:10.1016/j.redox.2020.101530 · Cited by 535
The Aryl Hydrocarbon Receptor in Barrier Organ Physiology, Immunology, and Toxicology
Esser, C., & Rannug, A. (2015) · Pharmacological Reviews · doi:10.1124/pr.114.009001 · Cited by 501
Wollenberg, A., Christen‐Zäch, S., Taieb, A., Paul, C., Thyssen, J. P., de Bruin‐Weller, M., Vestergaard, C., Seneschal, J., Werfel, T., Cork, M. J., et al. (2020) · Journal of the European Academy of Dermatology and Venereology · doi:10.1111/jdv.16892 · Cited by 493
Furue, M. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21155382 · Cited by 419
Causes of epidermal filaggrin reduction and their role in the pathogenesis of atopic dermatitis
Thyssen, J. P., & Kežić, S. (2014) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2014.06.014 · Cited by 411
Wollenberg, A., Oranje, A. P., Deleuran, M. S., Simon, D., Szalai, Z. Z., Kunz, B., Svensson, Å., Barbarot, S., von Kobyletzki, L., Taı̈eb, A., et al. (2016) · Journal of the European Academy of Dermatology and Venereology · doi:10.1111/jdv.13599 · Cited by 396
Tapinarof is a natural AhR agonist that resolves skin inflammation in mice and humans.
Smith, S. H., Jayawickreme, C., Rickard, D. J., Nicodeme, E., Bui, T., Simmons, C., Coquery, C. M., Neil, J., Pryor, W. M., Mayhew, D., et al. (2017) · Journal of Investigative Dermatology · doi:10.1016/j.jid.2017.05.004 · Cited by 387
Activation of the Aryl Hydrocarbon Receptor Dampens the Severity of Inflammatory Skin Conditions
Di Meglio, P., Duarte, J. H., Ahlfors, H., Owens, N. D. L., Li, Y., Villanova, F., Tosi, I., Hirota, K., Nestle, F. O., Mrowietz, U., et al. (2014) · Immunity · doi:10.1016/j.immuni.2014.04.019 · Cited by 373
New Insights into Atopic Dermatitis: Role of Skin Barrier and Immune Dysregulation
Leung, D. Y. M. (2013) · Allergology International · doi:10.2332/allergolint.13-rai-0564 · Cited by 337
Uberoi, A., Bartow‐McKenney, C., Zheng, Q., Flowers, L. J., Campbell, A. E., Knight, S. A. B., Chan, N., Wei, M. H., Lovins, V. M., Bugayev, J., et al. (2021) · Cell Host & Microbe · doi:10.1016/j.chom.2021.05.011 · Cited by 328
Atopic dermatitis: immune deviation, barrier dysfunction, IgE autoreactivity and new therapies
Furue, M., Chiba, T., Tsuji, G., Ulzii, D., Kido‐Nakahara, M., Nakahara, T., & Kadono, T. (2017) · Allergology International · doi:10.1016/j.alit.2016.12.002 · Cited by 324
The use of skin models in drug development
Mathes, S. H., Ruffner, H., & Graf‐Hausner, U. (2014) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2013.12.006 · Cited by 328
Atopic dermatitis: the skin barrier and beyond
Tsakok, T., Woolf, R., Smith, C. H., Weidinger, S., & Flohr, C. (2018) · British Journal of Dermatology · doi:10.1111/bjd.16934 · Cited by 298
Fang, Z., Pan, T., Li, L., Wang, H., Zhu, J., Zhang, H., Zhao, J., Chen, W., & Lu, W. (2022) · Gut Microbes · doi:10.1080/19490976.2022.2044723 · Cited by 273
Hidaka, T., Ogawa, E., Kobayashi, E. H., Suzuki, T., Funayama, R., Nagashima, T., Fujimura, T., Aiba, S., Nakayama, K., Okuyama, R., et al. (2017) · Nature Immunology · doi:10.1038/ni.3614 · Cited by 274
Fibroblast heterogeneity and its implications for engineering organotypic skin models in vitro
Sriram, G., Bigliardi, P. L., & Bigliardi‐Qi, M. (2015) · European Journal of Cell Biology · doi:10.1016/j.ejcb.2015.08.001 · Cited by 314
Yu, J., Luo, Y., Zhu, Z., Zhou, Y., Sun, L., Gao, J., Sun, J., Wang, G., Yao, X., & Li, W. S. (2018) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2018.11.036 · Cited by 262
Oxidative Stress in Atopic Dermatitis
Ji, H., & Li, X. (2016) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2016/2721469 · Cited by 218
Aryl Hydrocarbon Receptor in Atopic Dermatitis and Psoriasis
Furue, M., Hashimoto-Hachiya, A., & Tsuji, G. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20215424 · Cited by 215
Niehues, H., Bouwstra, J. A., El Ghalbzouri, A., Brandner, J. M., Zeeuwen, P. L. J. M., & van den Bogaard, E. H. (2018) · Experimental Dermatology · doi:10.1111/exd.13531 · Cited by 210
Self-citationImmortalized N/TERT keratinocytes as an alternative cell source in 3D human epidermal models
Smits, J. P. H., Niehues, H., Rikken, G., van Vlijmen‐Willems, I. M. J. J., van de Zande, G. W. H. J. F., Zeeuwen, P. L. J. M., Schalkwijk, J., & van den Bogaard, E. H. J. (2017) · Scientific Reports · doi:10.1038/s41598-017-12041-y · Cited by 212
Self-citationDijkhoff, I. M., Drasler, B., Karakocak, B. B., Petri-Fink, A., Valacchi, G., Eeman, M., & Rothen-Rutishauser, B. (2020) · Particle and Fibre Toxicology · doi:10.1186/s12989-020-00366-y · Cited by 202
Fang, Z., Li, L., Zhang, H., Zhao, J., Lu, W., & Chen, W. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.720393 · Cited by 200
Therapeutic pipeline for atopic dermatitis: End of the drought?
Paller, A. S., Kabashima, K., & Bieber, T. (2017) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2017.07.006 · Cited by 192
Nrf2-A regulator of keratinocyte redox signaling
Schäfer, M., & Werner, S. (2015) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2015.04.018 · Cited by 192
Bissonnette, R., Stein Gold, L., Rubenstein, D. S., Tallman, A. M., & Armstrong, A. (2021) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2020.10.085 · Cited by 181
Atopic dermatitis and filaggrin
Cabanillas, B., & Novak, N. (2016) · Current Opinion in Immunology · doi:10.1016/j.coi.2016.05.002 · Cited by 182
The role of transcription factor Nrf2 in skin cells metabolism
Gęgotek, A., & Skrzydlewska, E. (2015) · Archives of Dermatological Research · doi:10.1007/s00403-015-1554-2 · Cited by 180
Role of AhR/ARNT system in skin homeostasis
Furue, M., Takahara, M., Nakahara, T., & Uchi, H. (2014) · Archives of Dermatological Research · doi:10.1007/s00403-014-1481-7 · Cited by 175
Particulate matter causes skin barrier dysfunction.
Kim, B. E., Kim, J., Goleva, E., Berdyshev, E., Lee, J., Vang, K. A., Lee, U. H., Han, S., Leung, S., Hall, C. F., et al. (2021) · JCI insight · doi:10.1172/jci.insight.145185 · Cited by 173
“Additionally, we demonstrated that FLG and LOR were inhibited by PM2.”
BackgroundInfluentialvan den Bogaard, E. H. J., Tjabringa, G. S., Joosten, I., Vonk-Bergers, M., van Rijssen, E., Tijssen, H. J., Erkens, M., Schalkwijk, J., & Koenen, H. J. P. M. (2013) · Journal of Investigative Dermatology · doi:10.1038/jid.2013.417 · Cited by 173
Self-citationSkin barrier dysfunction and filaggrin
Kim, Y., & Lim, K. (2021) · Archives of Pharmacal Research · doi:10.1007/s12272-021-01305-x · Cited by 179
Transcription factor p63 bookmarks and regulates dynamic enhancers during epidermal differentiation
Kouwenhoven, E. N., Oti, M., Niehues, H., van Heeringen, S. J., Schalkwijk, J., Stunnenberg, H. G., van Bokhoven, H., & Zhou, H. (2015) · EMBO Reports · doi:10.15252/embr.201439941 · Cited by 165
Self-citationPetrolatum: Barrier repair and antimicrobial responses underlying this “inert” moisturizer
Czarnowicki, T., Malajian, D., Khattri, S., Correa da Rosa, J., Dutt, R., Finney, R., Dhingra, N., Xiangyu, P., Xu, H., Estrada, Y. D., et al. (2016) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2015.08.013 · Cited by 161
Nygaard, U., Hvid, M., Johansen, C., Buchner, M., Fölster‐Holst, R., Deleuran, M. S., & Vestergaard, C. (2016) · Journal of the European Academy of Dermatology and Venereology · doi:10.1111/jdv.13679 · Cited by 158
Furue, M. (2020) · Journal of Clinical Medicine · doi:10.3390/jcm9113741 · Cited by 161
Aryl hydrocarbon receptor activation restores filaggrin expression via OVOL1 in atopic dermatitis
Tsuji, G., Hashimoto-Hachiya, A., Kiyomatsu-Oda, M., Takemura, M., Ohno, F., Ito, T., Morino-Koga, S., Mitoma, C., Nakahara, T., Uchi, H., et al. (2017) · Cell Death & Disease · doi:10.1038/cddis.2017.322 · Cited by 149
Cole, C., Kroboth, K., Schurch, N., Sandilands, A., Sherstnev, A., O’Regan, G. M., Watson, R. M., McLean, W. H. I., Barton, G. J., Irvine, A. D., et al. (2014) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2014.04.021 · Cited by 142
Gene regulation of filaggrin and other skin barrier proteins via aryl hydrocarbon receptor
Furue, M., Tsuji, G., Mitoma, C., Nakahara, T., Chiba, T., Morino-Koga, S., & Uchi, H. (2015) · Journal of Dermatological Science · doi:10.1016/j.jdermsci.2015.07.011 · Cited by 132
Grishanova, A. Y., & Perepechaeva, M. L. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23126719 · Cited by 130
Basics and recent advances in the pathophysiology of atopic dermatitis
Nakahara, T., Kido‐Nakahara, M., Tsuji, G., & Furue, M. (2020) · The Journal of Dermatology · doi:10.1111/1346-8138.15664 · Cited by 142
Influence of nutrient-derived metabolites on lymphocyte immunity
Veldhoen, M., & Ferreira, C. (2015) · Nature Medicine · doi:10.1038/nm.3894 · Cited by 125
Aryl Hydrocarbon Receptor in Keratinocytes Is Essential for Murine Skin Barrier Integrity
Haas, K., Weighardt, H., Deenen, R., Köhrer, K., Clausen, B., Zahner, S., Boukamp, P., Bloch, W., Krutmann, J., & Esser, C. (2016) · Journal of Investigative Dermatology · doi:10.1016/j.jid.2016.06.627 · Cited by 125
Skin barrier in atopic dermatitis
Kezic, S. (2014) · Frontiers in Bioscience · doi:10.2741/4225 · Cited by 115
Haarmann-Stemmann, T., Esser, C., & Krutmann, J. (2015) · Journal of Investigative Dermatology · doi:10.1038/jid.2015.285 · Cited by 113
Furue, M., Uchi, H., Mitoma, C., Hashimoto-Hachiya, A., Chiba, T., Ito, T., Nakahara, T., & Tsuji, G. (2017) · Nutrients · doi:10.3390/nu9030223 · Cited by 113
Vieyra-Garcia, P. A., & Wolf, P. (2020) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2020.107784 · Cited by 114
The IL ‐13– OVOL 1– FLG axis in atopic dermatitis
Furue, K., Ito, T., Tsuji, G., Ulzii, D., Vu, Y. H., Kido‐Nakahara, M., Nakahara, T., & Furue, M. (2019) · Immunology · doi:10.1111/imm.13120 · Cited by 107
van den Bogaard, E. H. J., Podolsky, M. A., Smits, J. P. H., Cui, X., John, C., Gowda, K., Desai, D. H., Amin, S., Schalkwijk, J., Perdew, G. H., et al. (2015) · Journal of Investigative Dermatology · doi:10.1038/jid.2015.6 · Cited by 107
Self-citationLycopene prevents DEHP-induced hepatic oxidative stress damage by crosstalk between AHR–Nrf2 pathway
Zhao, Y. P., Bao, R., Zhu, S., Talukder, M., Cui, J.-G., Zhang, H., Li, X., & Li, J. (2021) · Environmental Pollution · doi:10.1016/j.envpol.2021.117080 · Cited by 105
Skin Barrier in Atopic Dermatitis
Schmuth, M., Eckmann, S., Moosbrugger‐Martinz, V., Ortner, D., Blunder, S., Trafoier, T., Gruber, R. W., & Elias, P. M. (2024) · Journal of Investigative Dermatology · doi:10.1016/j.jid.2024.03.006 · Cited by 111
Szelest, M., Walczak, K., & Plech, T. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22031104 · Cited by 102
Christoffers, W. A., Coenraads, P., Svensson, Å., Diepgen, T. L., Dickinson-Blok, J. L., Xia, J., & Williams, H. C. (2019) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd004055.pub2 · Cited by 96
Keratinocytes: An Enigmatic Factor in Atopic Dermatitis
Das, P., Mounika, P., Yellurkar, M. L., Prasanna, V. S., Sarkar, S., Ravichandiran, V., & Arumugam, S. (2022) · Cells · doi:10.3390/cells11101683 · Cited by 97
Role of the Aryl Hydrocarbon Receptor in Environmentally Induced Skin Aging and Skin Carcinogenesis
Vogeley, C., Esser, C., Tüting, T., Krutmann, J., & Haarmann‐Stemmann, T. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20236005 · Cited by 90
Smits, J. P. H., Ederveen, T. H. A., Rikken, G., van den Brink, N. J. M., van Vlijmen‐Willems, I. M. J. J., Boekhorst, J., Kamsteeg, M., Schalkwijk, J., van Hijum, S. A. F. T., Zeeuwen, P. L. J. M., et al. (2019) · Journal of Investigative Dermatology · doi:10.1016/j.jid.2019.06.142 · Cited by 91
Self-citationTapinarof validates the aryl hydrocarbon receptor as a therapeutic target: A clinical review
Silverberg, J. I., Boguniewicz, M., Quintana, F. J., Clark, R. A., Gross, L., Hirano, I., Tallman, A. M., Brown, P. M., Fredericks, D., Rubenstein, D. S., et al. (2023) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2023.12.013 · Cited by 94
Targeting Skin Barrier Function in Atopic Dermatitis
van den Bogaard, E. H. J., Elias, P. M., Goleva, E., Berdyshev, E. V., Smits, J. P. H., Danby, S. G., Cork, M. J., & Leung, D. Y. M. (2023) · The Journal of Allergy and Clinical Immunology In Practice · doi:10.1016/j.jaip.2023.02.005 · Cited by 86
From TCDD-mediated toxicity to searches of physiologic AHR functions
Bock, K. W. (2018) · Biochemical Pharmacology · doi:10.1016/j.bcp.2018.07.032 · Cited by 90
CYP1A1 Enzymatic Activity Influences Skin Inflammation Via Regulation of the AHR Pathway
Kyoreva, M., Li, Y., Hoosenally, M., Hardman, J. A., Morrison, K., Tosi, I., Tolaini, M., Barinaga, G., Stockinger, B., Mrowietz, U., et al. (2020) · Journal of Investigative Dermatology · doi:10.1016/j.jid.2020.11.024 · Cited by 84
The shifting perception on antioxidants: The case of vitamin E and β-carotene
Vrolijk, M. F., Opperhuizen, A., Jansen, E. H. J. M., Godschalk, R., van Schooten, F., Bast, A., & Haenen, G. R. M. M. (2015) · Redox Biology · doi:10.1016/j.redox.2014.12.017 · Cited by 82
Takei, K., Mitoma, C., Hashimoto‐Hachiya, A., Uchi, H., Takahara, M., Tsuji, G., Kido‐Nakahara, M., Nakahara, T., & Furue, M. (2015) · The Journal of Dermatology · doi:10.1111/1346-8138.12717 · Cited by 81
The Aryl Hydrocarbon Receptor and the Maintenance of Lung Health
Guerrina, N., Traboulsi, H., Eidelman, D. H., & Baglole, C. J. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19123882 · Cited by 79
Franciosi, J. P., Mougey, E. B., Dellon, E. S., Gutiérrez‐Junquera, C., Fernández‐Fernández, S., Venkatesh, R. D., & Gupta, S. K. (2022) · Journal of Asthma and Allergy · doi:10.2147/jaa.s274524 · Cited by 81
Kim, K., Kim, H., & Sung, G. Y. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23042116 · Cited by 77
Addressing treatment challenges in atopic dermatitis with novel topical therapies
Silverberg, J. I., Nelson, D. B., & Yosipovitch, G. (2016) · Journal of Dermatological Treatment · doi:10.1080/09546634.2016.1174765 · Cited by 68
Emerging Treatment Options in Atopic Dermatitis: Systemic Therapies
Nygaard, U., Vestergaard, C., & Deleuran, M. S. (2017) · Dermatology · doi:10.1159/000484406 · Cited by 67
Manipulating Microbiota to Treat Atopic Dermatitis: Functions and Therapies
Alam, J., Xie, L., Yap, Y. A., Marques, F. Z., & Robert, R. (2022) · Pathogens · doi:10.3390/pathogens11060642 · Cited by 71
Mineral oil in food, cosmetic products, and in products regulated by other legislations
Pirow, R., Blume, A., Hellwig, N., Herzler, M., Huhse, B., Hutzler, C., Pfaff, K., Thierse, H., Tralau, T., Vieth, B., et al. (2019) · Critical Reviews in Toxicology · doi:10.1080/10408444.2019.1694862 · Cited by 67
Noakes, R. (2015) · International Journal of Tryptophan Research · doi:10.4137/ijtr.s19985 · Cited by 68
Fang, Z., Pan, T., Wang, H., Zhu, J., Zhang, H., Zhao, J., Chen, W., & Lu, W. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23147735 · Cited by 65
Targeting the Complexity of In Vitro Skin Models: A Review of Cutting-Edge Developments
Quílez, C., Bebiano, L. B., Jones, E., Maver, U., Meesters, L., Parzymies, P., Petiot, E., Rikken, G., Risueño, I., Zaidi, H., et al. (2024) · Journal of Investigative Dermatology · doi:10.1016/j.jid.2024.04.032 · Cited by 65
Particulate Matter and Its Molecular Effects on Skin: Implications for Various Skin Diseases
Paik, K., Na, J.-I., Huh, C.-H., & Shin, J.-W. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25189888 · Cited by 64
Dvořák, Z., Sokol, H., & Mani, S. (2020) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2020.09.013 · Cited by 65
Ming, M., Zhao, B., Shea, C. R., Shah, P., Qiang, L., White, S. R., Sims, D. M., & He, Y. (2014) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2014.09.035 · Cited by 63
AHR and NRF2 in Skin Homeostasis and Atopic Dermatitis
Edamitsu, T., Taguchi, K., Okuyama, R., & Yamamoto, M. P. (2022) · Antioxidants · doi:10.3390/antiox11020227 · Cited by 64
Hong, C., Lee, C., Yu, H., & Huang, S.-K. (2016) · International Immunopharmacology · doi:10.1016/j.intimp.2016.04.017 · Cited by 61
The Landscape of AhR Regulators and Coregulators to Fine-Tune AhR Functions
Gargaro, M., Scalisi, G., Manni, G., Mondanelli, G., Grohmann, U., & Fallarino, F. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22020757 · Cited by 63
The role of the OVOL1–OVOL2 axis in normal and diseased human skin
Tsuji, G., Ito, T., Chiba, T., Mitoma, C., Nakahara, T., Uchi, H., & Furue, M. (2018) · Journal of Dermatological Science · doi:10.1016/j.jdermsci.2018.02.005 · Cited by 60
Role of Aryl Hydrocarbon Receptor Activation in Inflammatory Chronic Skin Diseases
Napolitano, M., Fabbrocini, G., Martora, F., Picone, V., Morelli, P., & Patruno, C. (2021) · Cells · doi:10.3390/cells10123559 · Cited by 59
Punj, S., Kopparapu, P., Jang, H. S., Phillips, J. L., Pennington, J. M., Rohlman, D., O’Donnell, E. F., Iversen, P. L., Kolluri, S. K., & Kerkvliet, N. I. (2014) · PLoS ONE · doi:10.1371/journal.pone.0088726 · Cited by 58
Blunder, S., Rühl, R., Moosbrugger‐Martinz, V., Krimmel, C., Geisler, A., Zhu, H., Crumrine, D. A., Elias, P. M., Gruber, R. W., Schmuth, M., et al. (2016) · Journal of Investigative Dermatology · doi:10.1016/j.jid.2016.09.034 · Cited by 58
Hashimoto‐Hachiya, A., Tsuji, G., Murai, M., Yan, X., & Furue, M. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19061654 · Cited by 59
Aryl hydrocarbon receptor (AhR) a possible target for the treatment of skin disease
Napolitano, M., & Patruno, C. (2018) · Medical Hypotheses · doi:10.1016/j.mehy.2018.05.001 · Cited by 56
Mari, O. D. A., Uchi, H., Morino‐Koga, S., & Furue, M. (2018) · Journal of Dermatological Science · doi:10.1016/j.jdermsci.2018.02.014 · Cited by 53
Sumitomo, A., Siriwach, R., Thumkeo, D., Ito, K., Nakagawa, R., Tanaka, N., Tanabe, K., Watanabe, A., Kishibe, M., Ishida‐Yamamoto, A., et al. (2018) · Journal of Investigative Dermatology · doi:10.1016/j.jid.2018.10.034 · Cited by 53
The Role of KEAP1-NRF2 System in Atopic Dermatitis and Psoriasis
Ogawa, T., & Ishitsuka, Y. (2022) · Antioxidants · doi:10.3390/antiox11071397 · Cited by 55
Vehicles for atopic dermatitis therapies: more than just a placebo
Danby, S. G., Draelos, Z. D., Gold, L. S., Cha, A., Vlahos, B. L., Aikman, L., Sanders, P. W., Wu‐Linhares, D., & Cork, M. J. (2020) · Journal of Dermatological Treatment · doi:10.1080/09546634.2020.1789050 · Cited by 52
Epidermal equivalents of filaggrin null keratinocytes do not show impaired skin barrier function
Niehues, H., Schalkwijk, J., van Vlijmen‐Willems, I. M. J. J., Rodijk‐Olthuis, D., van Rossum, M. M., Wladykowski, E., Brandner, J. M., van den Bogaard, E. H. J., & Zeeuwen, P. L. J. M. (2016) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2016.09.016 · Cited by 50
Self-citationNew insights in the pathogenesis of atopic dermatitis
Ong, P. Y. (2013) · Pediatric Research · doi:10.1038/pr.2013.196 · Cited by 52
Rademacher, F., Simanski, M., Hesse, B., Dombrowsky, G., Vent, N., Gläser, R., & Harder, J. (2018) · Journal of Innate Immunity · doi:10.1159/000492162 · Cited by 50
Vu, Y. H., Hashimoto‐Hachiya, A., Takemura, M., Yumine, A., Mitamura, Y., Nakahara, T., Furue, M., & Tsuji, G. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21249412 · Cited by 52
Traffic-related air pollution and eczema in the elderly: findings from the SALIA cohort.
Schnass, W., Hüls, A., Vierkötter, A., Krämer, U., Krutmann, J., & Schikowski, T. (2018) · International Journal of Hygiene and Environmental Health · doi:10.1016/j.ijheh.2018.06.002 · Cited by 50
How Ah Receptor Ligand Specificity Became Important in Understanding Its Physiological Function
Murray, I. A., & Perdew, G. H. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21249614 · Cited by 57
Dębińska, A. (2021) · Journal of Clinical Medicine · doi:10.3390/jcm10112506 · Cited by 52
Metadata
- Authors
- van den Bogaard, E. H., Bergboer, J. G. M., Vonk-Bergers, M., van Vlijmen-Willems, I. M. J. J., Hato, S. V., van der Valk, P. G. M., Schröder, J. M., Joosten, I., Zeeuwen, P. L. J. M., & Schalkwijk, J.
- Affiliations
- Radboud University Medical Center (NL)
- University Hospital Schleswig-Holstein (DE)
- Radboud University Nijmegen (NL)
- Venue
- Journal of Clinical Investigation
- Published
- 2013-01-25
- Volume
- 123
- Issue
- 2
- Pages
- 917-27
- ISSN
- 0021-9738 (ISSN-L)
- PMC
- PMC3561798
- OpenAlex
- W2047893094
- Cited by
- 373
- References
- 64
- Citations by year
- 2026: 15 · 2025: 21 · 2024: 36 · 2023: 31 · 2022: 38 · 2021: 33 · 2020: 34 · 2019: 25 · 2018: 33 · 2017: 30 · 2016: 18 · 2015: 19 · 2014: 28 · 2013: 12
- FWCI
- 30.00
- Type
- journal article
- Language
- en
- Open access
- green
- europepmc.org
- Locations
- Journal of Clinical Investigation (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Radboud Repository (Radboud University) (submittedVersion)
- Radboud Repository (Radboud University) (submittedVersion, other-oa)
- Topics
- Health Sciences › Medicine › Dermatology › Dermatology and Skin Diseases
- Health Sciences › Medicine › Dermatology › Contact Dermatitis and Allergies
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmaceutical Science › Advancements in Transdermal Drug Delivery
- Keywords
- coal tar, atopic dermatitis, aryl hydrocarbon receptor, skin barrier repair, filaggrin, Th2 cytokines, IL-4, IL-13, Nrf2 signaling, epidermal differentiation, keratinocytes, spongiosis, CCL26, organotypic skin model
- MeSH terms
- Filaggrin Proteins, Administration, Topical, Cell Differentiation, Cells, Cultured, Coal Tar, Dermatitis, Atopic, Humans, Intermediate Filament Proteins, Models, Biological, Signal Transduction, Keratinocytes, Up-Regulation, Cytokines, Receptors, Aryl Hydrocarbon, Oxidative Stress, Th2 Cells, RNA, Small Interfering, NF-E2-Related Factor 2
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review